CN103993425A - Preparing method of polycaprolactone-keratin composite nano fiber film - Google Patents
Preparing method of polycaprolactone-keratin composite nano fiber film Download PDFInfo
- Publication number
- CN103993425A CN103993425A CN201410263724.5A CN201410263724A CN103993425A CN 103993425 A CN103993425 A CN 103993425A CN 201410263724 A CN201410263724 A CN 201410263724A CN 103993425 A CN103993425 A CN 103993425A
- Authority
- CN
- China
- Prior art keywords
- keratin
- polycaprolactone
- solution
- preparation
- composite nanofiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Materials For Medical Uses (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Abstract
本发明涉及一种聚己内酯-角蛋白复合纳米纤维膜的制备方法,包括:将聚己内酯溶于溶剂中,搅拌溶解,得到聚己内酯溶液;将角蛋白溶于溶剂中,搅拌溶解,得到角蛋白溶液;将聚己内酯溶液与角蛋白溶液按质量比为95∶5-5∶95混合,搅拌混匀,得到纺丝液,然后进行静电纺丝,即得。本发明通过静电纺丝的方法,将天然生物大分子材料角蛋白与聚己内酯复合制备成纳米纤维膜,使该纳米纤维膜在具备高孔隙率的同时,显示出良好的力学及生物学性能。The invention relates to a preparation method of a polycaprolactone-keratin composite nanofiber film, comprising: dissolving polycaprolactone in a solvent, stirring and dissolving to obtain a polycaprolactone solution; dissolving keratin in a solvent, Stir and dissolve to obtain a keratin solution; mix the polycaprolactone solution and the keratin solution at a mass ratio of 95:5-5:95, stir and mix evenly to obtain a spinning solution, and then perform electrostatic spinning to obtain the product. In the present invention, the natural biomacromolecular material keratin and polycaprolactone are compounded into a nanofiber membrane through an electrospinning method, so that the nanofiber membrane exhibits good mechanical and biological properties while having a high porosity. performance.
Description
技术领域technical field
本发明属于纳米纤维膜的制备领域,特别涉及一种聚己内酯-角蛋白复合纳米纤维膜的制备方法。The invention belongs to the field of preparation of nanofiber membranes, in particular to a preparation method of polycaprolactone-keratin composite nanofiber membranes.
背景技术Background technique
角蛋白是一种不溶性的纤维状动物蛋白质,是外胚层细胞的结构蛋白,广泛存在于动物皮肤及皮肤附属物中,如毛发、蹄、壳、爪、角、鳞片等。近几年的大量研究表明,角蛋白是一种生物相容性好且不被机体免疫排斥的优质生物医用材料,具有广阔的应用前景。目前,国内外已开展大量关于角蛋白生物材料的基础研究及动物实验研究,在创伤敷料[Wound Repair and Regeneration,2012,20:236-242]、人造骨[Journal of Bioactive andCompatible Polymers,2013,28:141-153]以及神经修复[Biomaterials34(2013)5907-5914]等方面都取得了良好效果,并有部分产品应用于临床。Keratin is an insoluble fibrous animal protein, a structural protein of ectodermal cells, widely present in animal skin and skin appendages, such as hair, hooves, shells, claws, horns, scales, etc. A large number of studies in recent years have shown that keratin is a high-quality biomedical material with good biocompatibility and not rejected by the body's immune system, and has broad application prospects. At present, a large number of basic research and animal experiment research on keratin biomaterials have been carried out at home and abroad. :141-153] and nerve repair [Biomaterials34 (2013) 5907-5914] and other aspects have achieved good results, and some products have been used clinically.
但现有研究证明,由于角蛋白的分子量较低,单一的角蛋白材料制成的膜材料通常较脆,且力学强度不高,使其应用性受到限制。因此,目前,大多数的角蛋白基生物材料往往采用角蛋白与天然高分子或人工高分子复合,这样既可以保持以改善单一角蛋白力学性能较差的不足,如丝素蛋白[Biomacromolecules,2008,9,1299–1305]、PVA[Advances inMaterials Science and Engineering,2014,Article ID163678]、PLGA[Journal of Bioactive andCompatible Polymers,2013,28:141-153]、PLLA[Biomed.Mater.2013,8:1-9]等。聚己内酯(PCL)是一种商业化的;医用高分子材料,具有良好的生物相容性和可降解性,已通过美国药监局的批准,被广泛应用于药物载体、软组织修复、组织工程材料等生物医用领域。因此,本发明开发了一种基于聚己内酯和角蛋白两种材料的复合材料。同时,为了获得具有高孔隙率的膜状材料,本发明采用静电纺丝的方法制备聚己内酯和角蛋白复合膜。静电纺丝技术是指利用高压电场环境使聚合物纺丝液形成带电的喷射流,该喷射流在电场作用下被拉长,溶剂挥发,最后在接收装置上形成一定形态的纳米纤维。近十几年来,该技术已成为制备纳米纤维材料的有效途径之一,所得纳米纤维孔隙率高,形态可控,被广泛应用于医用敷料、组织工程支架等领域。本发明所制备的聚己内酯-角蛋白复合纳米纤维膜即保持了角蛋白良好的生物活性,又具备聚己内酯良好的韧性和力学强度,有望应用于医用敷料等领域。However, existing studies have shown that due to the low molecular weight of keratin, the membrane material made of a single keratin material is usually brittle and has low mechanical strength, which limits its application. Therefore, at present, most keratin-based biomaterials often use keratin and natural polymers or artificial polymers, which can maintain and improve the poor mechanical properties of single keratin, such as silk fibroin [Biomacromolecules, 2008 ,9,1299–1305], PVA[Advances in Materials Science and Engineering,2014,Article ID163678], PLGA[Journal of Bioactive and Compatible Polymers,2013,28:141-153], PLLA[Biomed.Mater.2013,8:1 -9] etc. Polycaprolactone (PCL) is a commercialized; medical polymer material, has good biocompatibility and degradability, has been approved by the US Food and Drug Administration, and is widely used in drug carriers, soft tissue repair, Tissue engineering materials and other biomedical fields. Therefore, the present invention develops a composite material based on two materials, polycaprolactone and keratin. At the same time, in order to obtain a film-like material with high porosity, the present invention adopts an electrospinning method to prepare a composite film of polycaprolactone and keratin. Electrospinning technology refers to the use of a high-voltage electric field environment to form a charged jet flow from the polymer spinning solution. The jet flow is elongated under the action of the electric field, the solvent is volatilized, and finally nanofibers of a certain shape are formed on the receiving device. In the past ten years, this technology has become one of the effective ways to prepare nanofiber materials. The obtained nanofibers have high porosity and controllable shape, and are widely used in medical dressings, tissue engineering scaffolds and other fields. The polycaprolactone-keratin composite nanofiber membrane prepared by the invention not only maintains good biological activity of keratin, but also has good toughness and mechanical strength of polycaprolactone, and is expected to be applied to fields such as medical dressings.
发明内容Contents of the invention
本发明所要解决的技术问题是提供一种聚己内酯-角蛋白复合纳米纤维膜的制备方法,该发明通过静电纺丝的方法,将天然生物大分子材料角蛋白与聚己内酯复合制备成纳米纤维膜,使该纳米纤维膜在具备高孔隙率的同时,显示出良好的力学及生物学性能。The technical problem to be solved by the present invention is to provide a preparation method of polycaprolactone-keratin composite nanofiber membrane, which is prepared by compounding natural biomacromolecular material keratin and polycaprolactone by electrospinning The nanofibrous membrane is formed into a nanofibrous membrane, so that the nanofibrous membrane exhibits good mechanical and biological properties while having high porosity.
本发明的一种聚己内酯-角蛋白复合纳米纤维膜的制备方法,包括:A kind of preparation method of polycaprolactone-keratin composite nanofiber film of the present invention comprises:
(1)将聚己内酯溶于溶剂中,搅拌溶解,得到聚己内酯溶液;(1) dissolving polycaprolactone in a solvent, stirring and dissolving to obtain a polycaprolactone solution;
(2)将角蛋白溶于溶剂中,搅拌溶解,得到角蛋白溶液;(2) dissolving keratin in a solvent, stirring and dissolving to obtain a keratin solution;
(3)将聚己内酯溶液与角蛋白溶液按质量比为95:5-5:95混合,搅拌混匀,得到纺丝液,然后进行静电纺丝,即得聚己内酯-角蛋白复合纳米纤维膜。(3) Mix polycaprolactone solution and keratin solution at a mass ratio of 95:5-5:95, stir and mix to obtain spinning solution, and then perform electrospinning to obtain polycaprolactone-keratin Composite nanofiber membrane.
所述步骤(1)中溶剂为乙酸或乙酸/甲酸混合溶液;其中乙酸的质量体积百分浓度大于或等于80%,乙酸/甲酸混合液中乙酸和甲酸的体积比为1:9-9:1。The solvent in the step (1) is acetic acid or acetic acid/formic acid mixed solution; wherein the mass volume percent concentration of acetic acid is greater than or equal to 80%, and the volume ratio of acetic acid and formic acid in the acetic acid/formic acid mixed solution is 1:9-9: 1.
所述步骤(1)中聚己内酯的平均分子量为70,000-90,000。The average molecular weight of the polycaprolactone in the step (1) is 70,000-90,000.
所述步骤(1)中聚己内酯溶液的浓度为80-100mg/ml。The concentration of the polycaprolactone solution in the step (1) is 80-100mg/ml.
所述步骤(2)中溶剂为甲酸或乙酸/甲酸混合溶液;其中甲酸的质量体积百分浓度大于或等于80%,乙酸/甲酸混合液中乙酸和甲酸的体积比为1:9-9:1。The solvent in the step (2) is formic acid or acetic acid/formic acid mixed solution; wherein the mass volume percent concentration of formic acid is greater than or equal to 80%, and the volume ratio of acetic acid and formic acid in the acetic acid/formic acid mixed solution is 1:9-9: 1.
所述步骤(2)中角蛋白溶液的浓度为10-20mg/ml。The concentration of the keratin solution in the step (2) is 10-20 mg/ml.
所述步骤(2)中角蛋白为采用还原法、氧化法、水解法得到的角蛋白。The keratin in the step (2) is the keratin obtained by reduction method, oxidation method and hydrolysis method.
所述步骤(2)中角蛋白为动物提取角蛋白或基因重组技术得到的角蛋白。The keratin in the step (2) is keratin extracted from animals or obtained by gene recombination technology.
所述的角蛋白可以从人发、羊毛、家禽羽毛、牛毛等人或动物毛发提取而得,也可以是来源于盲鳗等其它已报道的动物体,也可以是基因重组技术得到的角蛋白产物。The keratin can be extracted from human or animal hair such as human hair, wool, poultry feathers, cow hair, etc., or can be derived from other reported animals such as hagfish, or can be keratin obtained by genetic recombination technology. product.
所述步骤(2)中角蛋白的分子量为3-300kDa。The molecular weight of keratin in the step (2) is 3-300kDa.
所述步骤(3)中静电纺丝工艺参数为:电压13-35kV,接收距离8-22cm,纺丝速率为0.5-1.5ml/h,喷丝孔内径为0.7-0.9mm,纺丝温度20-30℃,纺丝湿度45-65%;以铝箔或布接收纳米丝。Electrospinning process parameters in the step (3) are: voltage 13-35kV, receiving distance 8-22cm, spinning rate 0.5-1.5ml/h, spinneret inner diameter 0.7-0.9mm, spinning temperature 20 -30°C, spinning humidity 45-65%; receive nanofilaments with aluminum foil or cloth.
所述步骤(3)中所得的聚己内酯-角蛋白复合纳米纤维膜用于医用创伤敷料。The polycaprolactone-keratin composite nanofiber membrane obtained in the step (3) is used for medical wound dressing.
所述步骤(3)中所得的纳米纤维膜为三维网状结构,纤维直径为50-800nm。The nanofibrous membrane obtained in the step (3) has a three-dimensional network structure, and the fiber diameter is 50-800nm.
有益效果Beneficial effect
本发明通过静电纺丝的方法,将天然生物大分子材料角蛋白与聚己内酯复合制备成纳米纤维膜,使该纳米纤维膜在具备高孔隙率的同时,显示出良好的力学及生物学性能。In the present invention, the natural biomacromolecular material keratin and polycaprolactone are compounded into a nanofiber membrane through an electrospinning method, so that the nanofiber membrane exhibits good mechanical and biological properties while having a high porosity. performance.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
实施例1Example 1
将质量为0.8g,分子量范围为70,000-90,000的聚己内酯溶于10ml、体积比为30/70的乙酸/甲酸混合液中,室温下进行磁力搅拌至完全溶解,得到浓度为质量80mg/ml的聚己内酯溶液。将0.2g角蛋白固体溶于10ml甲酸,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比60:40的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为0.5ml/h,喷丝孔内径为0.7mm,纺丝温度25℃,纺丝湿度50%。以铝箔为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。Dissolve 0.8 g of polycaprolactone with a molecular weight range of 70,000-90,000 in 10 ml of acetic acid/formic acid mixture with a volume ratio of 30/70, and magnetically stir at room temperature until completely dissolved to obtain a concentration of 80 mg/ ml of polycaprolactone solution. 0.2 g of solid keratin was dissolved in 10 ml of formic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution are mixed according to the mass ratio of 60:40, and magnetically stirred until the mixture is uniform. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 15kV, receiving distance 12cm, spinning rate 0.5ml/h, spinneret inner diameter 0.7mm, spinning temperature 25°C , Spinning humidity 50%. The aluminum foil is used as a receiver to receive the nano-filaments produced by the jet, and the polycaprolactone-keratin composite nano-fiber membrane is obtained.
实施例2Example 2
将质量为1.0g,分子量范围为70,000-90,000的聚己内酯溶于10ml乙酸中,室温下进行磁力搅拌至完全溶解,得到浓度为质量100mg/ml的聚己内酯溶液。将0.15g角蛋白固体溶于纯甲酸中,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比50:50的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压13kV,接收距离10cm,纺丝速率为0.8ml/h,喷丝孔内径为0.7mm,纺丝温度30℃,纺丝湿度65%。以铝箔为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。Dissolve 1.0 g of polycaprolactone with a molecular weight of 70,000-90,000 in 10 ml of acetic acid, and magnetically stir at room temperature until completely dissolved to obtain a polycaprolactone solution with a concentration of 100 mg/ml. 0.15 g of solid keratin was dissolved in pure formic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 15 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 50:50, and magnetically stirred until uniformly mixed. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 13kV, receiving distance 10cm, spinning rate 0.8ml/h, spinneret inner diameter 0.7mm, spinning temperature 30°C , Spinning humidity 65%. The aluminum foil is used as a receiver to receive the nano-filaments produced by the jet, and the polycaprolactone-keratin composite nano-fiber membrane is obtained.
实施例3Example 3
将质量为1.0g,分子量范围为70,000-90,000的聚己内酯溶于10ml、体积比为10/90的乙酸/甲酸混合液中,室温下进行磁力搅拌至完全溶解,得到浓度为质量100mg/ml的聚己内酯溶液。将0.15g角蛋白固体溶于10ml、体积比为10/90的乙酸/甲酸混合液中,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比95:5的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压13kV,接收距离8cm,纺丝速率为1.5ml/h,喷丝孔内径为0.9mm,纺丝温度20℃,纺丝湿度45%。以铝箔为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。Dissolve 1.0 g of polycaprolactone with a molecular weight range of 70,000-90,000 in 10 ml of acetic acid/formic acid mixture with a volume ratio of 10/90, and stir magnetically at room temperature until it is completely dissolved to obtain a concentration of 100 mg/ ml of polycaprolactone solution. Dissolve 0.15 g of solid keratin in 10 ml of acetic acid/formic acid mixture with a volume ratio of 10/90, and magnetically stir at room temperature until completely dissolved to obtain a keratin solution with a concentration of 15 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 95:5, and magnetically stirred until the mixture was uniform. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 13kV, receiving distance 8cm, spinning rate 1.5ml/h, spinneret inner diameter 0.9mm, spinning temperature 20°C , Spinning humidity 45%. The aluminum foil is used as a receiver to receive the nano-filaments produced by the jet, and the polycaprolactone-keratin composite nano-fiber membrane is obtained.
实施例4Example 4
将质量为0.8g,分子量范围为70,000-90,000的聚己内酯溶于10ml、体积比为90/10的乙酸/甲酸混合液中,室温下进行磁力搅拌至完全溶解,得到浓度为质量80mg/ml的聚己内酯溶液。将0.2g角蛋白固体溶于10ml、体积比为90/10的乙酸/甲酸混合液中,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比5:95的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压35kV,接收距离22cm,纺丝速率为1.5ml/h,喷丝孔内径为0.9mm,纺丝温度20℃,纺丝湿度55%。以布为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。Dissolve 0.8 g of polycaprolactone with a molecular weight range of 70,000-90,000 in 10 ml of acetic acid/formic acid mixture with a volume ratio of 90/10, and magnetically stir at room temperature until completely dissolved to obtain a concentration of 80 mg/ ml of polycaprolactone solution. Dissolve 0.2 g of solid keratin in 10 ml of acetic acid/formic acid mixture with a volume ratio of 90/10, and magnetically stir at room temperature until completely dissolved to obtain a keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 5:95, and magnetically stirred until the mixture was uniform. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 35kV, receiving distance 22cm, spinning rate 1.5ml/h, spinneret inner diameter 0.9mm, spinning temperature 20°C , Spinning humidity 55%. The cloth is used as a receiver to receive the jet-generated nanofilaments, and a polycaprolactone-keratin composite nanofiber membrane is obtained.
实施例5Example 5
将质量为0.8g,分子量范围为70,000-90,000的聚己内酯溶于10ml乙酸,室温下进行磁力搅拌至完全溶解,得到浓度为质量80mg/ml的聚己内酯溶液。将0.15g角蛋白固体溶于10ml乙酸,室温下进行磁力搅拌至完全溶解,得到浓度为15mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比95:5的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为1.0ml/h,喷丝孔内径为0.7mm,纺丝温度15℃,纺丝湿度55%。以铝箔为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。Dissolve 0.8 g of polycaprolactone with a molecular weight of 70,000-90,000 in 10 ml of acetic acid, and magnetically stir at room temperature until completely dissolved to obtain a polycaprolactone solution with a concentration of 80 mg/ml. 0.15 g of solid keratin was dissolved in 10 ml of acetic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 15 mg/ml. The above polycaprolactone and keratin solution were mixed according to the mass ratio of 95:5, and magnetically stirred until the mixture was uniform. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 15kV, receiving distance 12cm, spinning rate 1.0ml/h, spinneret inner diameter 0.7mm, spinning temperature 15°C , Spinning humidity 55%. The aluminum foil is used as a receiver to receive the nano-filaments produced by the jet, and the polycaprolactone-keratin composite nano-fiber membrane is obtained.
实施例6Example 6
将质量为1.0g,分子量范围为70,000-90,000的聚己内酯溶于10ml、体积比为30/70Dissolve polycaprolactone with a mass of 1.0g and a molecular weight range of 70,000-90,000 in 10ml at a volume ratio of 30/70
的乙酸/甲酸混合液,室温下进行磁力搅拌至完全溶解,得到浓度为质量100mg/ml的聚己内酯溶液。将0.2g角蛋白固体溶于10ml乙酸,室温下进行磁力搅拌至完全溶解,得到浓度为20mg/ml的角蛋白溶液。将上述聚己内酯与角蛋白溶液按照质量比90:10的比例进行混合,磁力搅拌至混合均匀。将上述所得聚己内酯/角蛋白溶液进行静电纺丝,静电纺丝参数为电压15kV,接收距离12cm,纺丝速率为1.2ml/h,喷丝孔内径为0.7mm,纺丝温度15℃,纺丝湿度55%。以铝箔为接收器接收喷射产生的纳米丝,得到聚己内酯-角蛋白复合纳米纤维膜。The acetic acid/formic acid mixture was magnetically stirred at room temperature until it was completely dissolved to obtain a polycaprolactone solution with a concentration of 100 mg/ml. 0.2 g of solid keratin was dissolved in 10 ml of acetic acid, and magnetically stirred at room temperature until completely dissolved to obtain a keratin solution with a concentration of 20 mg/ml. The above polycaprolactone and keratin solution are mixed according to the mass ratio of 90:10, and magnetically stirred until the mixture is uniform. The polycaprolactone/keratin solution obtained above was subjected to electrospinning, the electrospinning parameters were voltage 15kV, receiving distance 12cm, spinning rate 1.2ml/h, spinneret inner diameter 0.7mm, spinning temperature 15°C , Spinning humidity 55%. The aluminum foil is used as a receiver to receive the nano-filaments produced by the jet, and the polycaprolactone-keratin composite nano-fiber membrane is obtained.
实施例7Example 7
按照实施例1中所述的制备方法制备聚己内酯-角蛋白复合纳米纤维膜,经分析测定,复合纳米纤维材料在干燥状态下的断裂强度为1.4MPa,断裂伸长率为60%,孔隙率93%。以血管内皮细胞为细胞模型,采用扫描电子显微镜观察细胞在材料上的黏附形态,并通过MTT法对细胞的增殖行为进行评价,结果表明,内皮细胞在复合纳米纤维材料上表现出良好的黏附形态和增殖行为,与单一聚己内酯纳米纤维膜相比具有显著性差异。按照实施例1中所述的制备方法,以单一的角蛋白制备的纳米纤维膜在干燥状态下脆性强、易破碎。Prepare polycaprolactone-keratin composite nanofiber membrane according to the preparation method described in embodiment 1, measure through analysis, the fracture strength of composite nanofiber material in dry state is 1.4MPa, and elongation at break is 60%, The porosity is 93%. Taking vascular endothelial cells as the cell model, the adhesion morphology of cells on the material was observed by scanning electron microscope, and the proliferation behavior of cells was evaluated by MTT method. The results showed that endothelial cells showed good adhesion morphology on the composite nanofiber material. And proliferation behavior, compared with single polycaprolactone nanofibrous membrane, there are significant differences. According to the preparation method described in Example 1, the nanofibrous membrane prepared from a single keratin is highly brittle and easily broken in a dry state.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410263724.5A CN103993425A (en) | 2014-06-13 | 2014-06-13 | Preparing method of polycaprolactone-keratin composite nano fiber film |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410263724.5A CN103993425A (en) | 2014-06-13 | 2014-06-13 | Preparing method of polycaprolactone-keratin composite nano fiber film |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103993425A true CN103993425A (en) | 2014-08-20 |
Family
ID=51307743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410263724.5A Pending CN103993425A (en) | 2014-06-13 | 2014-06-13 | Preparing method of polycaprolactone-keratin composite nano fiber film |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103993425A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784744A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Compound method for preparing wound dressing by utilizing human hair keratin |
| CN104784758A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
| CN107519524A (en) * | 2017-09-21 | 2017-12-29 | 滨州医学院 | A kind of polycaprolactone/collagen/quaternary ammonium salt electrospun composite fibers film and preparation method thereof |
| CN108179547A (en) * | 2017-12-19 | 2018-06-19 | 东华大学 | A kind of preparation method of the fluorescent nano-fiber film as heavy metal antimony Visual retrieval device |
| CN114427119A (en) * | 2022-01-21 | 2022-05-03 | 华中科技大学 | Preparation method and application of frozen electrostatic spinning of polymer fiber membrane |
| CN116084085A (en) * | 2021-11-05 | 2023-05-09 | 亚格生技股份有限公司 | Preparation method of nanofiber film |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101502671A (en) * | 2009-02-05 | 2009-08-12 | 东华大学 | Method for preparing silk fibroin/ P(LLA-CL) compound nano fiber structure repair stand |
| CN101507843A (en) * | 2009-03-20 | 2009-08-19 | 中国人民解放军第三军医大学 | Multi-purpose surgery biology patching material |
| US20110140312A1 (en) * | 2003-03-31 | 2011-06-16 | Teijin Limited | Composite of support matrix and collagen, and method for production of support matrix and composite |
| CN103341209A (en) * | 2013-07-08 | 2013-10-09 | 苏州大学 | Silk fibroin nanofiber membrane and preparation method thereof |
-
2014
- 2014-06-13 CN CN201410263724.5A patent/CN103993425A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110140312A1 (en) * | 2003-03-31 | 2011-06-16 | Teijin Limited | Composite of support matrix and collagen, and method for production of support matrix and composite |
| CN101502671A (en) * | 2009-02-05 | 2009-08-12 | 东华大学 | Method for preparing silk fibroin/ P(LLA-CL) compound nano fiber structure repair stand |
| CN101507843A (en) * | 2009-03-20 | 2009-08-19 | 中国人民解放军第三军医大学 | Multi-purpose surgery biology patching material |
| CN103341209A (en) * | 2013-07-08 | 2013-10-09 | 苏州大学 | Silk fibroin nanofiber membrane and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 谢军军等: "不同组分电纺丝素蛋白/聚己内酯超细纤维膜与小鼠成纤维细胞的相容性", 《中国组织工程研究与临床康复》, vol. 13, no. 29, 16 July 2009 (2009-07-16), pages 5532 - 5536 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784744A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Compound method for preparing wound dressing by utilizing human hair keratin |
| CN104784758A (en) * | 2015-05-09 | 2015-07-22 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
| CN104784758B (en) * | 2015-05-09 | 2017-05-10 | 南京师范大学 | Preparation method of polymer/keratin composite anticoagulation vascular tissue engineering scaffold |
| CN107519524A (en) * | 2017-09-21 | 2017-12-29 | 滨州医学院 | A kind of polycaprolactone/collagen/quaternary ammonium salt electrospun composite fibers film and preparation method thereof |
| CN108179547A (en) * | 2017-12-19 | 2018-06-19 | 东华大学 | A kind of preparation method of the fluorescent nano-fiber film as heavy metal antimony Visual retrieval device |
| CN116084085A (en) * | 2021-11-05 | 2023-05-09 | 亚格生技股份有限公司 | Preparation method of nanofiber film |
| CN114427119A (en) * | 2022-01-21 | 2022-05-03 | 华中科技大学 | Preparation method and application of frozen electrostatic spinning of polymer fiber membrane |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103993424B (en) | Preparing method of polyurethane-keratin composite nano fiber film | |
| Nemati et al. | Current progress in application of polymeric nanofibers to tissue engineering | |
| Zamani et al. | Recent advances in cell electrospining of natural and synthetic nanofibers for regenerative medicine | |
| Zhao et al. | Preparation of nanofibers with renewable polymers and their application in wound dressing | |
| CN104004221B (en) | Method for preparing polycaprolactone-keratin composite porous scaffolds | |
| CN104018247B (en) | The preparation method of a kind of urethane-Keratin sulfate composite nano fiber tubular material | |
| CN101230150B (en) | Method for preparing pure sodium alginate nano fiber membrane material | |
| CN100551449C (en) | Tussah silk fibroin biomedical material and preparation method thereof | |
| Hajiali et al. | Alginate nanofibrous mats with adjustable degradation rate for regenerative medicine | |
| Sadeghi et al. | Electrospun polyvinyl alcohol/gelatin/chondroitin sulfate nanofibrous scaffold: Fabrication and in vitro evaluation | |
| CN103993425A (en) | Preparing method of polycaprolactone-keratin composite nano fiber film | |
| US11801328B2 (en) | Electrospun nanofibers and membrane | |
| JP2020520344A (en) | Fibroin-containing nanofibers and hydrogels and systems containing said nanofibers | |
| CN104005179A (en) | Method for preparing polycaprolactone-keratin composite nanometer fiber pipe | |
| KR101616345B1 (en) | Complex scaffold comprising nanofiber with nanoparticle to drug-delivery for artificial skin and filler, and method for preparing the same | |
| CN101575771A (en) | Method for preparing blending electrospun fiber membrane by adopting membrane protein contained in avian egg shells | |
| Andrade et al. | Latex and natural rubber: processing techniques for biomedical applications | |
| CN102277654B (en) | Preparation method of hyaluronic acid and chitosan composite polyelectrolyte nanofibers | |
| Bafande et al. | Features and methods of making nanofibers by electrospinning, phase separation and self-assembly | |
| CN105839407A (en) | Surface bio-functionalization method of medical polymer material nanofiber | |
| CN104017230A (en) | Preparation method of polyurethane-keratin composite film | |
| Poshina et al. | Electrospinning of polysaccharides for tissue engineering applications | |
| KR101292791B1 (en) | Manufacturing method of natural polymer nanofibers for controlling porosity and thickness | |
| CN104018245B (en) | A kind of preparation method of fibroin albumen/keratin composite nano fiber tubular material | |
| CN115613219B (en) | Multifunctional medical material and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140820 |
|
| RJ01 | Rejection of invention patent application after publication |